Xiao Ying, Kry Stephen F, Popple Richard, Yorke Ellen, Papanikolaou Niko, Stathakis Sotirios, Xia Ping, Huq Saiful, Bayouth John, Galvin James, Yin Fang-Fang
Thomas Jefferson University Hospital.
J Appl Clin Med Phys. 2015 May 8;16(3):5219. doi: 10.1120/jacmp.v16i3.5219.
This report describes the current state of flattening filter-free (FFF) radiotherapy beams implemented on conventional linear accelerators, and is aimed primarily at practicing medical physicists. The Therapy Emerging Technology Assessment Work Group of the American Association of Physicists in Medicine (AAPM) formed a writing group to assess FFF technology. The published literature on FFF technology was reviewed, along with technical specifications provided by vendors. Based on this information, supplemented by the clinical experience of the group members, consensus guidelines and recommendations for implementation of FFF technology were developed. Areas in need of further investigation were identified. Removing the flattening filter increases beam intensity, especially near the central axis. Increased intensity reduces treatment time, especially for high-dose stereotactic radiotherapy/radiosurgery (SRT/SRS). Furthermore, removing the flattening filter reduces out-of-field dose and improves beam modeling accuracy. FFF beams are advantageous for small field (e.g., SRS) treatments and are appropriate for intensity-modulated radiotherapy (IMRT). For conventional 3D radiotherapy of large targets, FFF beams may be disadvantageous compared to flattened beams because of the heterogeneity of FFF beam across the target (unless modulation is employed). For any application, the nonflat beam characteristics and substantially higher dose rates require consideration during the commissioning and quality assurance processes relative to flattened beams, and the appropriate clinical use of the technology needs to be identified. Consideration also needs to be given to these unique characteristics when undertaking facility planning. Several areas still warrant further research and development. Recommendations pertinent to FFF technology, including acceptance testing, commissioning, quality assurance, radiation safety, and facility planning, are presented. Examples of clinical applications are provided. Several of the areas in which future research and development are needed are also indicated.
本报告描述了在传统直线加速器上实现的无均整器(FFF)放射治疗束的当前状态,主要面向执业医学物理学家。美国医学物理师协会(AAPM)的治疗新兴技术评估工作组成立了一个写作小组来评估FFF技术。对已发表的关于FFF技术的文献以及供应商提供的技术规格进行了审查。基于这些信息,并辅以小组成员的临床经验,制定了FFF技术实施的共识指南和建议。确定了需要进一步研究的领域。去除均整器会增加射束强度,尤其是在中心轴附近。强度增加会减少治疗时间,特别是对于高剂量立体定向放射治疗/放射外科手术(SRT/SRS)。此外,去除均整器会降低射野外剂量并提高射束建模精度。FFF射束有利于小射野(例如SRS)治疗,适用于调强放射治疗(IMRT)。对于大靶区的传统三维放射治疗,与均整后的射束相比,FFF射束可能不利,因为FFF射束在靶区内的不均匀性(除非采用调制)。对于任何应用,相对于均整后的射束,在调试和质量保证过程中需要考虑非均匀射束特性和显著更高的剂量率,并且需要确定该技术的适当临床应用。在进行设施规划时也需要考虑这些独特特性。几个领域仍需进一步研究和开发。本文提出了与FFF技术相关的建议,包括验收测试、调试、质量保证、辐射安全和设施规划。提供了临床应用实例。还指出了未来需要进行研究和开发的几个领域。